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The culture of human corneal endothelial cells (CECs) is critical for the development of suitable graft alternative on biodegradable
material, speciﬁcally for endothelial keratoplasty, which can potentially alleviate the global shortage of transplant-grade donor
corneas available. However, the propagation of slow proliferative CECs in vitro can be hindered by rapid growing stromal corneal
ﬁbroblasts (CSFs) that may be coisolated in some cases. The purpose of this study was to evaluate a strategy using magnetic cell
separation (MACS) technique to deplete the contaminating CSFs from CEC cultures using antiﬁbroblast magnetic microbeads.
Separated “labeled” and “ﬂow-through” cell fractions were collected separately, cultured, and morphologically assessed. Cells
from the “ﬂow-through” fraction displayed compact polygonal morphology and expressed Na+/K+ATPase indicative of corneal
endothelial cells, whilst cells from the “labeled” fraction were mostly elongated and ﬁbroblastic. A separation eﬃcacy of 96.88%
was observed. Hence, MACS technique can be useful in the depletion of contaminating CSFs from within a culture of CECs.
1.Introduction
The inner monolayer of the human cornea—the corneal
endothelium (CE)—functions both as a barrier and a pump
andplaysacriticalroleintheregulationofcornealhydration.
The CE layer prevents excessive ﬂuids from entering the
glycosaminoglycan-rich stromal layer while actively pump-
ing ﬂuid out to prevent corneal edema [1–3]. This maintains
corneal thickness and keeps the corneal transparent [3,
4]. Cells of the CE do not have the capacity to undergo
functional regeneration in vivo [5–7]. Hence, when corneal
endothelial cell loss occurs, the existing cells spread out to
maintain functional integrity of the CE. However, a critical
threshold must be maintained to preserve corneal clarity. If
endothelial dysfunction develops, there will be an inability
to eﬃciently pump ﬂuid out of the stroma, resulting in
stromal and epithelial edema, loss of corneal clarity, and
visual acuity [4], which will eventually lead to corneal
blindness—a situation where the retina is normal but the
cornea becomes edematous. This is the second leading cause
of visual blindness worldwide [8]. Restoration of vision in
these situations is only possible by replacing the dysfunc-
tionalCElayerwithhealthydonorCEthroughcornealtrans-
plantation.
There is a global shortage of transplant-grade donor
corneal tissues, and this greatly restricts the number of
corneal transplantation performed yearly [9, 10]. Hence,
signiﬁcant eﬀorts have been garnered for the development
of tissue-engineered cultured endothelial cells that may
potentially circumvent the shortage of transplant-grade
donor corneas [11]. To facilitate the development of a tissue-
engineered endothelium, the ability to cultivate the human
corneal endothelial cells (CECs) in an in vitro culture system
is critical [12, 13].2 International Journal of Biomaterials
The isolation and cultivation methods for the expan-
sion of CECs evolved over the years and varied greatly
between laboratories [14–20]. The current CECs isolated
protocol used was adapted from a two-step “peel-and-
digest” approach [21], using cadaveric research-grade donor
corneas, whereby Descemet’s membrane (DM), together
with the corneal endothelium layer, is peeled oﬀ from the
donor cornea before being subjected to enzymatic digestion
using collagenase. However, this technique may result in
the coisolation of contaminating stromal keratocytes in
cases where the DM layer is diﬃcult to peel and requires
lengthymanipulation[8].Inourexperience,thisisespecially
so in donor corneas obtained from very young donors
(unpublished observations). In these cases, a thin piece of
posterior stroma can be partially torn oﬀ during the pro-
longed manipulation process and remains inconspicuously
adhered to the DM-endothelial layer. Enzymatic dissociation
to isolate the CECs from the DM layer will also release
the undesired stromal keratocytes into the culture sys-
tem. Subsequent exposure to complex serum-supplemented
medium required for the culture and expansion of CECs
will inevitably turn the contaminating stromal keratocytes
into rapid growing stromal ﬁbroblasts [22]. In isolations
of primary CECs with ﬁbroblastic contamination, we and
others have found that the overgrowth of corneal stromal
ﬁbroblasts (CSFs) usually become apparent within 4 to 5
days of culture and will outgrow the less proliferative CECs
within 7 days in culture [8, 23]. This is detrimental to
the aﬀected CEC cultures which generally take between
14 to 21 days to establish and will negatively impact on
the development of tissue-engineered constructs where pure
populations of cultivated functional CECs are required [8].
Furthermore, the consequence of ﬁbroblastic contamination
in these cultures will interfere with the critical barrier and
pump function of the cultivated CECs [24]. Hence, there lies
the need for methods to eliminate the contaminating CSFs.
Magnetic cell separation (MACS) technique using mag-
netic particles at both the micro- and nanoscale have been
well described as standard tools for the isolation, puriﬁ-
cation, or separation of deﬁned subset of cells, based on
their speciﬁc cell-surface antigenic expression, in modern
cell biology and immunology [25, 26]. The present study is
aimed to evaluate the feasibility of using MACS technology
to deplete contaminating CSFs from expanding CECs.
2.MaterialsandMethods
2.1.Isolation andGrowthof HumanCornealEndothelial Cells.
A total of three pairs research-grade corneoscleral tissues
from cadaver human donors considered unsuitable for
transplantation were obtained from Lions Eye Institute for
Transplant and Research (Tampa, FL, USA). These research
c o r n e a s ,f r o md o n o r sb e t w e e n2 4t o3 3y e a r s ,w e r ep r e s e r v e d
andtransportedinOptisol-GSat4◦Candpr oc essedbetw een
7t o1 2d a y sf r o mp r e s e r v a t i o n( Table 1). Primary CECs
were isolated using a modiﬁed two-step, peel-and-digest
method. After three 15-minute washes in a PBS buﬀered
antibiotic/antimycotic solution, the DM together with the
Table 1: Donor information.
Serial
Number Age Sex Days to Culture Cause of Death
01 33 M 7 Acute Cardiac Crisis
02 24 F 12 Acute Cardiac Crisis
03 28 M 9 Overdose
Cultures of human corneal endothelial cells were established from donors
aged 24 year-old to 33 year-old. Days taken from death of donor to the
initiation of corneal endothelial cell culture ranged from 7 days to 12 days
with a median of 9 days.
corneal endothelial cells, anterior to Schwalbe’s line, within
a 9.0mm diameter, was carefully peeled oﬀ from the
stroma under a dissecting stereomicroscope. Paired DM-
endothelial layer obtained were pooled and treated with
collagenase (2mg/mL; Roche, Mannheim, Germany) for
at least 2 hours. The resultant CEC clusters were further
dissociated into smaller clumps using TrypLE Express (TE;
Invitrogen,Carlsbad,CA,USA)forapproximately5minutes.
Isolated CECs were cultured on FnC mixture (United States
Biologicals, Swampscott, MA, USA) coated culture plates,
in F99 medium (a 1:1 mixture of Ham’s F12 (Invitrogen)
and M199 (Invitrogen) media), supplemented with 5% fetal
bovine serum (Invitrogen), 20μg/mL ascorbic acid (Sigma,
St. Louis, MO, USA), 1x insulin-transferrin-selenium (Invit-
rogen),1xantibiotic/antimycotic(Invitrogen),and10ng/mL
of basic ﬁbroblast growth factor (bFGF, R&D Systems,
Minneapolis, MN, USA). After the primary cultures of CECs
reached conﬂuency at P0, as well as in subsequent passages,
cells were dissociated using TE and subcultured on FnC-
coated culture wares at a plating density of ∼7,500cells/cm2.
For this study, CECs were utilized at the third passage. All
incubation and cell culture were carried out in a humidiﬁed
incubator (Binder, Bohemia, NY, USA) at 37◦C containing
5% CO2.
2.2. Isolation and Growth of Human Corneal Stromal Fibrob-
last. After the DM-endothelial layer has been peeled from
the stroma, an 8.5mm stroma button was obtained by
trephination. The corneal epithelial layer was carefully
scraped oﬀ using a scalpel blade. Stroma buttons (n = 3)
were washed twice in a PBS-buﬀered antibiotic/antimycotic
solutionandenzymaticallydigestedincollagenaseovernight.
The following day, stromal keratocytes released from within
the stroma button were brieﬂy washed twice with PBS,
seeded onto cell culture ﬂask coated with FNC coating mix-
ture, and cultured in F99 medium. The exposure to a serum-
supplemented medium transformed the corneal stromal
keratocytes into CSFs. Culture medium was refreshed every
two days, and conﬂuent ﬁbroblast cultures were passaged
usingTrypLEExpressina1:5splitratio.Forthisstudy,CSFs
were utilized at the eighth passage.
2.3. Labeling Corneal Stromal Fibroblast with CMFDA
CellTracker Green. In order to assess the eﬃcacy of the
cell separation, cultured CSFs (n = 3) were prelabeled
with CellTracker Green, 5-chloromethylﬂuorescein diacetateInternational Journal of Biomaterials 3
(CMFDA; Invitrogen) as described [27]. Brieﬂy, CSFs were
incubated in a serum-free medium containing 5μMo f
CMFDA dye for 30 minutes at 37◦C. Subsequently, the
CMFDA dye containing medium was replaced with fresh
serum-free medium for another 30 minutes at 37◦Ct oa l l o w
the cellular metabolites of CMFDA to be removed, which
transforms the colorless and nonﬂuorescent CMFDA into a
brightly ﬂuorescent green product.
2.4. Magnetic Cell Separation and Determination of MACS
Eﬃcacy. Separate culture of CMFDA labeled CSFs and CECs
was each trypsinized using TrypLE Express (Invitrogen,
Carlsbad, CA, USA) and counted using a hemocytometer.
Subsequently, the CMFDA-labeled CSFs and CECs were
mixed in this study at a 1:1 ratio to achieve an approximated
50% mixture of CSFs and CECs within a suspension (n = 3).
The cell mixture was then washed once in PBS and imme-
diately resuspended in MACS buﬀer (PBS containing 2mM
EDTA, and 0.5% BSA) and incubated with antiﬁbroblast
magnetic microbeads (Miltenyi Biotech) for 15 minutes at
room temperature. This was followed by the resuspension
of the cell mixture in 500μLo fM A C Sb u ﬀer and applying
it to the MS column attached to the Mini-MACS separator
(Miltenyi Biotech). Subsequently, the column was washed
twice (500μL each) with MACS buﬀer. The total eﬄuent
wascollectedasthe“ﬂow-through”fraction.TheMScolumn
was then removed from the magnet, and the magnetically
retained cells within the column were ﬂushed out in 1mL of
MACS buﬀer by the means of a plunger. This eﬄuent was
collected as the “labeled fraction.” The “labeled” fraction,
“ﬂow-through” fraction, and an aliquot of the unsorted cell
mixture were collected separately and subcultured on FnC-
coated culture ware in F99 medium for further analysis
(n = 3). The eﬃcacy of MACS to deplete the CSFs from
the heterogeneous population of CSFs and CECs, mixed in
a 1:1 ratio, can be determined by the number of CMFDA-
labeledcellsfoundinthe“ﬂow-through”fraction1dayafter-
separation, using the formula:
E =

1 −
%F i b r o b l a s t post-separation
%F i b r o b l a s t pre-separation

×100%. (1)
2.5. Antibodies and Immunoﬂuorescence. At Day 3, sep-
arated cell fractions cultured on glass slides (n = 3)
were ﬁxed on the third day after-separation in 100% ice-
cold ethanol for 5 minutes. The ethanol-ﬁxed cells were
immersed in a PBS block solution containing 10% normal
goat serum. Following this, the samples were incubated
with primary and, subsequently, secondary antibody (in
the dark), each for 1 hour at room temperature. Between
each incubation steps, samples were washed twice with PBS.
Labeled cells were mounted onto coverslips in Vectorshield
mounting medium containing DAPI (Vector Laboratories).
The following primary antibody used was mouse IgG1 anti-
Na+/K+ATPase α1(5μg/mL;SantaCruzBiotechnology).The
secondary antibody used was Alexa Fluor 546 goat anti-
mouse IgG (2μg/mL; Invitrogen). Negative controls were
cells incubated with an anti-mouse IgG1 isotype control
(5μg/mL; BioLegends) in place of the primary antibody.
Fluorescent images of cells were examined using a Zeiss
Axioplan 2 ﬂuorescence microscope (Carl Zeiss, Germany).
Atleast250nucleiwereanalyzedfromﬁverandomlyselected
ﬁelds per experiment (n = 3).
2.6. Morphometry Analysis of Cellular Circularity. The
healthy corneal endothelial cells of the human corneal endo-
thelium are mostly hexagonal in shape [28, 29], and one of
the morphological characteristic of isolated human corneal
endothelial cells in vitro is the maintenance of the unique
polygonal cellular structure in culture [8, 30, 31]. Cell cir-
cularity can be determined using the formula: Circularity =
Perimeter2/(4π × Area), which quantiﬁes the roundness of
the cell assessed, where a value approaching 1.0 is equivalent
to a cell with a cellular proﬁle nearing circularity. Hence, the
p o l y g o n a lC E C sw i l lh a v eap r o ﬁ l ec l o s e rt o1 . 0c o m p a r e d
to the long and spindle-like CSFs. Digital micrographs of
cultured cells from separated “labeled” and “ﬂow-through”
fractions were taken on the third day after-separation. The
area and perimeter of randomly selected cells were analyzed
with Image J software (NIH, Bethesda, MD, USA). At least
100 cells from each of the “labeled” and “ﬂow-through”
fraction (n = 3) were analyzed.
2.7. Statistical Analysis. All numerical data obtained were
expressed as a mean ± standard deviation. Comparison
of cell circularity was statistically analyzed using Mann-
WhitneyU test(SPSSStatistics17.0,IBM,Chicago,IL,USA).
Values were deemed to be signiﬁcant when a signiﬁcance
level with a P value of less than 0.05 was achieved.
3. Results
3.1. Culture of Corneal Endothelial Cells. An established
monolayer of primary CECs isolated from the human cor-
neal endothelium takes between 14 to 21 days and can
be determined morphologically by their unique polygonal
cellular structure (Figure 1(a)). In comparison, an example
of a CECs culture contaminated with the CSFs contains het-
erogeneous cell populations with two distinct cell types, the
polygonalCECs(∗)andtheelongatedCSF(†)(Figure 1(b)).
3.2. CMFDA-Labeled CSFs and Mixture with Unlabeled
CECs. The CMFDA-labeled CSFs maintained bright green
ﬂuorescent after 3 days in culture (Figure 2(a)). However,
due to the rapidly expanding CSFs, the level of green ﬂuo-
rescent decreases exponentially and could not be detected by
ﬂuorescent microscopy by the seventh day in culture (results
not shown). The CMFDA-labeled CSFs and unlabeled CECs
were experimentally mixed at a 1:1 ratio and assessed 24
hours after the cell mixture were and left to adhere. Com-
posite phase contrast and ﬂuorescent image (Figure 2(b))
showed that CSFs constituted to approximately 55.38% ±
7.16% of the adhered mixed culture.
3.3. Separation Eﬃciency of Mixed CSFs and CECs Cultures.
The experimentally mixed cultures of CSFs and CECs were4 International Journal of Biomaterials
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Figure 1: (a) Representative micrograph of a conﬂuent homogeneous monolayer of successfully isolated human corneal endothelial cells
at Day 14. (b) Representative micrograph of a failed isolation attempt resulting in stromal contamination at Day 7. The cellular boundary
between the polygonal corneal endothelial cells (∗) and the conﬂuent elongated corneal stromal ﬁbroblasts (†) can be clearly deﬁned (scale
bars = 100μm).
(a) (b)
Cell mixture
Labeled
fraction
Flow-through
fraction
(c)
Figure 2: (a) Composite phase contrast and ﬂuorescent picture of corneal stromal ﬁbroblast labeled experimentally with CMFDA
CellTracker Green dye. (b) Culture of CMFDA labeled corneal stromal ﬁbroblast with human corneal endothelial cells 24 hours after mixing
at a 1:1 ratio. (c) Schematic of the MACS setup used in the study (scale bar = 100μm).International Journal of Biomaterials 5
Table 2: Eﬃcacy of MACS.
Fraction CMFDA Positive Cells
(%) Circularity Index
Unsorted Mixture 55.38 ±7.16 Not Measured
“Labeled” 81.66 ±3.46 2.61 ±1.10∗
“Flow-Through” 1.73 ±1.09 1.42 ±0.35∗
For the comparison of cell circularity index, signiﬁcance was achieved
betweenthe“labeled”and“ﬂow-through”fraction(z =− 9.62 ∗P<0.001).
The overall sorting eﬃcacy of MACS was calculated as 96.88% ± 3.50%.
subsequently tagged with antiﬁbroblast magnetic microb-
eads and subjected to the magnetic separation through the
MScolumnplacedwithinamagneticﬁeldandseparatedinto
the “labeled” and “ﬂow-through” fraction as depicted in the
schematic (Figure 2(c)).
The MAC-separated cells were left to adhere for at least
one day to enable the cells to establish their morphology,
and postseparation assessment of cultured ﬂuorescent cells
from both the “label” (Figure 3(a)) and “ﬂow-through”
(Figure 3(b)) fractions of the separated mixtures was per-
formed to determine the eﬃcacy of separation. Approx-
imately 81.66% ± 3.46% of the cells from the “labeled”
fraction were ﬂuorescent, compared to 1.73% ± 1.09%
from the “ﬂow-through” fraction following separation. The
eﬃcacy of separation was deemed to be approximately
96.88% ± 3.50% (Table 2).
3.4. Morphometric Assessment of Cellular Circularity. The
morphometric assessment of cultured cells from the “la-
beled” and “ﬂow-through” fractions of separated mixtures
was performed on the third day after-separation. At least 100
cells from each of the “labeled” and “ﬂow-through” fraction
were randomly selected and assessed for their cellular circu-
larity. The morphometric assessment showed that cultured
cells from the “ﬂow-through” fraction were “rounder” with a
circularity proﬁle of 1.42 ± 0.35, indicative of the polygonal
CECs, compared to the “labeled” fraction containing cells
of signiﬁcantly mixed circularity proﬁle of 2.61 ± 1.10 (P<
0.001; Figure 3(c); Table 2).
3.5. Expression of Ion Channel Na+/K+ATPase after MACS.
Majority of the cells in the “labeled” fraction were found
to be CMFDA positive with 12.3% ± 0.2% of the cells that
strongly expressed Na+/K+ATPase (Figure 4(a)). Conversely,
in the “ﬂow-through” fraction, approximately 98.66% ±
0.1% of the cells were Na+/K+ATPase positive (Figure 4(b)),
displaying a ubiquitous staining pattern.
4. Discussion
The capacity to propagate primary CECs in vitro is critical
for the development of alternative donor graft material
suitable for corneal transplantation. However, this process
can be hindered by the coisolation of the stromal keratocytes
located within the adjacent layer of the cornea. These
contaminating corneal stromal keratocytes will transform
into fast growing CSFs in the presence of complex culture
medium containing serum, which is crucial for the extended
culture of CECs. Rapid growth of contaminating CSFs
will outgrow and impede the growth of CECs and will
hinderthedevelopmentoftissue-engineeredgraftalternative
where a pure population of cultivated CECs is required,
and the use of CSFs-contaminated CECs will impede
the functional integrity of the engineered graft substitute
rending the construct ineﬀective. The two-step “peel-and-
digest” method used currently involves peeling of the DM
layer within an approximated 9.0mm diameter to decrease
chances of coisolating noncorneal endothelial cells that lie
beyond the posterior Schwalbe’s line, which includes the
trabecular meshworks and the underlying cells with the
potential to turn into ﬁbroblasts. This restricts the isolation
of the most peripheral region of the corneal endothelium
layer, which has been shown to contain endothelial cells
that are more proliferative [32, 33]. Moreover, the human
cornea has a diameter of approximately 11.5mm. If a larger
area of the DM endothelial layer can be removed during
the isolation process with a solution to restrict potential
ﬁbroblastic overgrowth, the ﬁnal yield of the isolated CECs
for culture can be signiﬁcantly increased. For example, the
diﬀerence in the amount of CECs isolated between taking
an area of 9.0mm and an area of 11.0mm with a corneal
endothelial density cell count of 2,000cells per mm2 equates
to a 33.06% diﬀerence or approximately 63,000 cells from a
single donor cornea.
Engelmann and colleagues previously reported that
ﬁbroblastic contamination could be eliminated from corneal
endothelial cell culture using a D-valine supplemented
medium that is L-valine-free [23], based on the rationale
that ﬁbroblasts lack the D-amino-acid oxidase required
for the conversion of D-valine to L-valine [34]. However,
complete elimination of L-valine and associated mitogens
known to promote the growth of ﬁbroblast from a culture
medium is cumbersome. For example, the serum used in the
medium was predialyzed for 24 hours three times against
a 50-fold volume of tissue culture grade water, and once
against a 2-to 3-fold volume of L-valine-free medium [23].
Furthermore, the dialysed serum was processed to be free
of potent ﬁbroblasts mitogens such as ﬁbroblast growth
factor and platelet-derived growth factor before they were
used in the supplementation of the selection medium [23].
For laboratories using diﬀerent culture medium in the
cultivation of CECs, these processes to remove L-valine, as
well as associated mitogens, must also be applied to the
other complex supplementation used in the medium, such
as bovine pituitary extract [35].
Cell separation using MACS technology can be per-
formed using two approaches, namely, positive selection in
which the antigens on the surface of the cell of interest
are targeted by speciﬁc antibody coupled with the magnetic
microbeads and negative depletion where microbeads used
target the unwanted cells and leave the cell of interest
untouched. However, since antigen speciﬁc to CECs has
yet been identiﬁed, a positive selection approach cannot be
utilized. Therefore, in this study, we adopted the negative
depletion method to purify the cultured CECs from the6 International Journal of Biomaterials
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Figure 3: Following MACS of experimentally mixed human corneal endothelial cells and corneal stromal ﬁbroblast using antiﬁbroblast
magnetic microbeads, cell fractions were subcultured as (a) the antiﬁbroblast magnetic microbeads “labeled” fraction and (b) unlabeled
“ﬂow-through” fraction, 3 days after sorting. (Scale bar = 100μm.) (c) A frequency histogram depicting the circularity of randomly selected
cells in the “labeled” and the “ﬂow-through” fractions. At least 100 cells from each fraction were counted.
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Figure 4: Composite ﬂuorescent micrograph images of CMFDA (green) and Na+/K+ATPase pumps (red) of cultured cells established from
(a) the “labeled” fraction and (b) the “ﬂow-through” fraction. Cell nuclei were counterstained with DAPI in blue. (Scale bar = 100μm.)International Journal of Biomaterials 7
contaminating CSFs within an experimental setting. This
method oﬀers a relatively simple alternate option to elimi-
nate ﬁbroblastic contamination that may occur following the
isolation and propagation of CECs. We and others showed
that separated cells from both the “labeled” and “ﬂow-
through” fractions could be subcultured, which enabled
downstream morphometric assessment and characterization
[26, 36]. Cultured cells from the “labeled” fraction were
found to contain 81.66% ± 3.46% ﬁbroblasts as shown by
their long and spindle-like morphology and green ﬂuo-
rescent CMFDA dye. In this fraction, the remaining cells,
approximately 12.3% ± 0.2% as judged by the expression
of Na+/K+ATPase, were the CECs, which were most likely
trappedwithinthemagnetizedcolumnduringtheseparation
process, and could only be recovered at the end of the
procedure together with the remaining labeled ﬁbroblasts
when they were ﬂushed out of the MS column. Morpho-
metric assessment of cellular circularity reﬂected the above
observation with a signiﬁcantly mixed cellular circularity
proﬁle detected in the “labeled” fraction. On the other hand,
cultured cells from the “ﬂow-through” fraction were more
homogeneous in terms of their circularity. Hence, for our
application to separate CECs from a mix culture of CECs
and CSFs, a negative selection approach appeared to be more
eﬃcient as compared to positive selection.
Activity of Na+/K+ATPases is associated with the liquid
pump function of the corneal and is critical for the
proper physiological control of corneal thickness by the
corneal endothelium [1, 37, 38]. The expression of the
Na+/K+ATPase not only showed the viability of the separated
CECs following MACS, it also suggests that the CECs
remained unaltered in their functionality.
From the expression of CMFDA dye, approximately
1.73% of the cells in the “ﬂow through” were deemed to
be the CSFs that have escaped the separation procedure.
Based on these observations, the eﬃcacy of MACS using
the antiﬁbroblast magnetic microbeads was deemed to be
over 96.88% in the present experimental setting, where the
CECs were mixed with the CSFs at a 1:1 ratio. However,
it should be noted that a minute amount of viable CSFs
that escaped the separation process, given enough time, will
be suﬃcient to overtake a culture of generally slow-growing
CECs. Application of the “ﬂow-through” fraction through
another magnetized MACS column may reduce the numbers
of contaminating ﬁbroblast further but will also increase the
numbers of CECs that become trapped within the column.
Alternatively, the cultured “ﬂow-through” fraction can be
closely monitored following MAC separation and regions
of rapid cell growth with spindly ﬁbroblastic morphology
can be immediately scrapped oﬀ manually under the dis-
secting microscope. The elimination of such ﬁbroblastic
contaminants via manual scraping is more plausible when
the contaminated regions are small.
5. Conclusion
In conclusion, our results demonstrated that current MACS
technology using the antiﬁbroblast magnetic microbeads
provides a simple alternative method to deplete majority of
thecontaminatingCSFsinsituationswherepreciouscultures
of CECs were found to be contaminated with rapid-growing
CSFs. Further development of this technology is required
to enable the complete depletion of all contaminating CSFs,
and this may involve the development of multiple magnetic
microbeads tagged antibodies detecting diﬀerent cell-surface
antigens expressed speciﬁcally by CSFs.
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